Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer
- 4 September 2006
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 26 (11) , 1616-1625
- https://doi.org/10.1038/sj.onc.1209951
Abstract
LKB1, mutated in Peutz–Jeghers and in sporadic lung tumours, phosphorylates a group of protein kinases named AMP-activated protein kinase (AMPK)-related kinases. Among them is included the AMPK, a sensor of cellular energy status. To investigate the relevance of LKB1 in lung carcinogenesis, we study several lung cancer cells with and without LKB1-inactivating mutations. We report that LKB1-mutant cells are deficient for AMPK activity and refractory to mTOR inhibition upon glucose depletion but not growth-factor deprivation. The requirement for wild-type LKB1 to properly activate AMPK is further demonstrated in genetically modified cancer cells. In addition, LKB1-deficient lung primary tumours had diminished AMPK activity, assessed by complete absence or low level of phosphorylation of its critical substrate, acetyl-CoA carboxylase. We also demonstrate that LKB1 wild-type cells are more resistant to cell death upon glucose withdrawal than their mutant counterparts. Finally, modulation of AMPK activity did not affect PI3K/AKT signalling, an advantage for the potential use of AMPK as a target for cancer therapy in LKB1 wild-type tumours. Thus, sustained abrogation of cell energetic checkpoint control, through alterations at key genes, appear to be an obligatory step in the development of some lung tumours.Keywords
This publication has 37 references indexed in Scilit:
- Akt-dependent transformation: there is more to growth than just survivingOncogene, 2005
- Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinasePublished by Elsevier ,2005
- Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutationsOncogene, 2004
- Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor geneOncogene, 2004
- MO25 / interact with STRAD / enhancing their ability to bind, activate and localize LKB1 in the cytoplasmThe EMBO Journal, 2003
- Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRADThe EMBO Journal, 2003
- United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signallingBiochemical Society Transactions, 2003
- Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formationOncogene, 2002
- Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinaseNature Genetics, 1998
- Increased Risk of Cancer in the Peutz–Jeghers SyndromeNew England Journal of Medicine, 1987